Leaders in Fertility Research

Reproductive Medicine Associates (RMA) has been a pioneer in fertility science since its inception in 1999, with an unwavering commitment to improving patient outcomes.

rma research

Research & Innovation

Over the years RMA has evolved to become one of the most trusted authorities on all aspects of infertility, including research, education and patient care. This unparalleled emphasis on research and innovation has made possible quantum leap advancements in the practice of In Vitro Fertilization (IVF) that have given rise to a new standard of care for the industry and a new benchmark of success for patients.

Raising the Bar

Today, due to advancements encouraging Single Embryo Transfer (SET), IVF with RMA means a drastic reduction in multiple births resulting in a lower risk for mothers and babies. RMA’s singleton babies are now born with the same weight and term delivery rates as those conceived naturally.

steps of ivf
infertile couple

Improving Outcomes

How has RMA reduced the burden of care so quickly? By investing tens of millions of dollars into studying one question: how can IVF lead to one healthy baby?

The answer required getting several steps exactly right, and each clinical trial done at RMA inched doctors closer to finding the answer. Still, everyday doctors at RMA are working to further advance the field, finding answers to new questions that can improve outcomes and help couples complete their families safely and in the shortest time possible.

With a state-of-the-art laboratory, embryologists, scientists, and doctors as passionate as they are skilled, and a tireless focus on discovery, RMA is a worldwide leader in turning ideas into science, science into success, and success into families.

Research Oriented

RMA’s research has spanned the field of assisted reproduction and sought to make new discoveries in the areas of diminished ovarian reserve, endometriosis, Polycystic Ovary Syndrome (PCOS), male fertility, egg freezing, embryo biopsy, and testing, mosaicism, the microbiome, fibroids, stem cell rejuvenation, extended embryo culture, and dozens of more topics.

RMA’s April 2017 merger with IVI, Europe’s biggest IVF provider, has only elevated the group’s scientific reach. Together, IVI-RMA Global is the single-biggest investor in IVF research in the world.

genetic testing fertilty treatment

Published Research

Since its founding in 1999, RMA has published hundreds of pieces of research – including more than a dozen clinical trials – in an effort to improve patient outcomes.

Below is a non-exhaustive list of published works. To learn about IVI-RMA Global’s research, visit our Innovation website at ivi-rmainnovation.com.

2011
CCS Efficacy Study

Blastocyst biopsy with CCS and fresh embryo transfer significantly increases IVF implantation and delivery rates: a randomized controlled trial. *This showed that CCS helped to improve embryo selection and therefore pregnancy and delivery rates.

Download the full study.

2009
Impact of Embryo Biopsy Study

Cleavage stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. *Study showed day 3 embryo biopsy was harmful while day 5 embryo biopsy was not. This showed that a biopsy performed at the blastocyst stage was safe to the embryo and had no untoward effect on IVF outcomes.

Download the full study.

1997
Cytoplasmic Transfer

Birth of infant after the transfer of anucleate donor oocyte cytoplasm into recipient eggs. *Study showed it’s possible to rejuvenate a poor quality egg with young mitochondria from a donor.

1989
Serum FSH

Follicle-stimulating hormone levels on day 3 are predictive of In Vitro Fertilization (IVF) outcome. *Study showed that FSH levels were predictive of IVF outcome. This allowed patients to have a better understanding of their fertility after their initial workup.

Speak to a Fertility Specialist & Get Started

Submit the form for an appointment. For immediate new patient scheduling, call 866-762-3140.

Call to ScheduleRequest We Call You
Schedule Your First Visit866-762-3140

Existing patients with inquiries, please call your local office or send a message via the Artemis Patient Portal.